Front Desk: 469-391-0070
Idelalisib: Comprehensive Guide to Leukemia and Lymphoma Treatment
Summary of Key Points
Idelalisib is a prescription medication used to treat certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). It works by inhibiting proteins that promote the growth of cancer cells. Idelalisib is taken orally, typically in tablet form, and is often used in combination with other cancer therapies. Always consult your healthcare provider before starting or adjusting your dose. You can also speak with one of our providers through telemedicine for more information.
Names of Medication
US Brand Name: Zydelig (Idelalisib)
The generic name refers to the active ingredient, while the brand name is assigned by the manufacturer. The generic name is listed in parentheses.
Pharmacologic Category
Phosphatidylinositol 3-kinase (PI3K) inhibitor
Idelalisib Dosage for Blood Cancer Treatment
Idelalisib is prescribed for various blood cancers in adults. The dosage may vary depending on the specific condition being treated. Always follow your doctor’s instructions carefully, and never adjust your dose without consulting a healthcare provider. If you have any questions about your treatment, you can schedule a telemedicine appointment with one of our providers.
Chronic Lymphocytic Leukemia (CLL)
The recommended dose is 150 mg taken orally twice daily. Treatment continues until the disease progresses or side effects become intolerable.
Follicular Lymphoma (FL)
The recommended dose is 150 mg taken orally twice daily. The duration of treatment depends on how well the cancer responds to the medication.
Small Lymphocytic Lymphoma (SLL)
The recommended dose is 150 mg taken orally twice daily. Treatment continues until disease progression or unacceptable toxicity occurs.
Marginal Zone Lymphoma (MZL)
The recommended dose is 150 mg taken orally twice daily. The length of treatment is based on the patient’s response and tolerance to the medication.
Non-Hodgkin Lymphoma (NHL)
The recommended dose is 150 mg taken orally twice daily. Treatment continues until the disease worsens or side effects necessitate discontinuation.
Lymphocytic Leukemia
The recommended dose is 150 mg taken orally twice daily. The duration of treatment is determined by your healthcare provider.
B-cell Malignancies
The recommended dose is 150 mg taken orally twice daily. Treatment continues until disease progression or unacceptable side effects occur.
Hairy Cell Leukemia
The recommended dose is 150 mg taken orally twice daily. The length of treatment is based on the patient’s response and tolerance to the medication.
Mantle Cell Lymphoma (MCL)
The recommended dose is 150 mg taken orally twice daily. Treatment continues until disease progression or unacceptable toxicity occurs.
Acute Lymphoblastic Leukemia (ALL)
The recommended dose is 150 mg taken orally twice daily. The duration of treatment depends on how well the cancer responds and any side effects experienced.
Dosage Forms and Strengths
Tablets: 150 mg, 100 mg
Administration Instructions for Idelalisib
Idelalisib is taken orally, usually in tablet form. It can be taken with or without food. Swallow the tablet whole with water; do not crush, chew, or break it. If you miss a dose, take it as soon as you remember, unless it’s almost time for your next dose. Do not take two doses at once. Always follow your healthcare provider’s instructions closely, and contact them if you have any questions. You can also schedule a telemedicine visit with one of our providers for guidance.
Idelalisib Side Effects and Adverse Reactions
Like all medications, Idelalisib can cause side effects. Not everyone will experience them, but it’s important to be aware of potential reactions. If you experience severe or persistent side effects, contact your healthcare provider immediately. You can also reach out to one of our telemedicine providers for advice.
Common Side Effects (affecting more than 10% of patients)
- Diarrhea: Frequent, loose stools. This is a common side effect and may require medication to manage.
- Fever: Elevated body temperature, which may indicate an infection or immune response.
- Nausea: Feeling sick to your stomach, which may lead to vomiting.
- Fatigue: Feeling unusually tired or weak.
Less Common Side Effects (affecting 1-10% of patients)
- Liver Problems: Elevated liver enzymes, which may indicate liver inflammation or damage.
- Pneumonitis: Inflammation of lung tissue, which can cause difficulty breathing.
- Severe Skin Reactions: Rashes or other skin issues that may require medical attention.
Rare Side Effects (affecting less than 1% of patients)
- Colitis: Inflammation of the colon, which can cause severe diarrhea and abdominal pain.
- Intestinal Perforation: A tear in the wall of the intestine, which is a medical emergency.
Contraindications for Idelalisib
A contraindication is a specific condition where a medication should not be used due to potential harm. Understanding these situations is crucial to avoid serious side effects or complications.
Contraindications for Taking Idelalisib
- Severe liver impairment: Idelalisib is processed by the liver, and in patients with severe liver disease, the drug may not be metabolized properly. This can lead to higher drug levels in the body, increasing the risk of toxicity.
- Allergic reactions to Idelalisib: If you have had a previous allergic reaction to Idelalisib or any of its ingredients, you should not take this medication. Allergic reactions can be life-threatening and may include symptoms such as rash, itching, swelling, or difficulty breathing.
- Active infections: Idelalisib can weaken the immune system, making it harder for your body to fight infections. If you have an active infection, taking Idelalisib could worsen your condition.
- History of pneumonitis: Idelalisib has been associated with lung inflammation (pneumonitis). If you have a history of this condition, taking Idelalisib could increase the risk of recurrence.
Drug to Drug Interactions
Idelalisib can interact with other medications, potentially affecting its effectiveness or increasing the risk of serious side effects. It’s important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements.
Medications That Interact with Idelalisib
Rifampin (Rifadin): This antibiotic can reduce the effectiveness of Idelalisib by speeding up its breakdown in the body.
Carbamazepine (Tegretol): Commonly used for seizures, this drug can lower the levels of Idelalisib in the blood, making it less effective.
Phenytoin (Dilantin): Another seizure medication that decreases Idelalisib’s effectiveness by increasing its metabolism in the liver.
St. John’s Wort: This herbal supplement, often used for depression, can reduce Idelalisib levels, diminishing its efficacy.
Ketoconazole (Nizoral): This antifungal can increase the levels of Idelalisib in the blood, which may lead to more side effects.
Idelalisib in Pregnancy
Is It Safe to Take Idelalisib When Pregnant?
Idelalisib is not recommended during pregnancy. Animal studies suggest it may harm a developing fetus, and there is limited data on its effects in pregnant women. If you are pregnant or planning to become pregnant, discuss alternative treatments with your healthcare provider. Effective contraception should be used during treatment and for at least one month after stopping Idelalisib.
Idelalisib While Breastfeeding
Is It Safe to Take Idelalisib While Breastfeeding?
Breastfeeding is not recommended while taking Idelalisib. Although it is unknown whether Idelalisib passes into breast milk, the potential for serious side effects in a nursing infant warrants caution. Consult your healthcare provider about alternative feeding options if you are on Idelalisib.
Estimated Cost of Idelalisib
The cost of Idelalisib can vary depending on your location and pharmacy. Without insurance, a 30-day supply of Idelalisib (150 mg) typically costs between $12,000 and $14,000 with a GoodRx coupon. Check with your pharmacy for accurate pricing, and inquire about financial assistance programs if needed.
Possible Alternatives to Idelalisib
If Idelalisib is not suitable for you, other treatment options are available depending on your specific type of cancer. Always consult your healthcare provider before making any changes to your treatment plan. You can also schedule a telemedicine appointment with one of our providers to explore these alternatives further.
Chronic Lymphocytic Leukemia (CLL) Treatment Alternatives
Ibrutinib (Imbruvica): A targeted therapy that inhibits a different enzyme involved in cancer cell growth.
Venetoclax (Venclexta): A BCL-2 inhibitor that promotes the death of cancer cells.
Rituximab (Rituxan): A monoclonal antibody that specifically targets cancer cells.
Follicular Lymphoma Treatment Options
Obinutuzumab (Gazyva): A monoclonal antibody often used in combination with chemotherapy.
Bendamustine (Treanda): A chemotherapy drug frequently combined with other treatments.
Small Lymphocytic Lymphoma (SLL) Treatment Options
Fludarabine: A chemotherapy agent typically used in combination with other drugs.
Chlorambucil (Leukeran): Another chemotherapy drug used to treat SLL.
Marginal Zone Lymphoma Treatment Options
Rituximab (Rituxan): Often a first-line treatment for marginal zone lymphoma.
Bendamustine (Treanda): Can be combined with Rituximab for treatment.
Non-Hodgkin Lymphoma Treatment Options
CHOP Chemotherapy: A combination of cyclophosphamide, doxorubicin, vincristine, and prednisone.
Lenalidomide (Revlimid): An immunomodulatory drug used in certain types of non-Hodgkin lymphoma.
Lymphocytic Leukemia Treatment Options
FCR regimen: A combination of fludarabine, cyclophosphamide, and rituximab.
Ofatumumab (Arzerra): A monoclonal antibody used to treat lymphocytic leukemia.
B-cell Malignancies Treatment Options
CAR T-cell therapy: A newer treatment that modifies your immune cells to target and destroy cancer cells.
Lenalidomide (Revlimid): Often used in B-cell malignancies to modulate the immune system.
Hairy Cell Leukemia Treatment Options
Cladribine (Leustatin): A chemotherapy agent commonly used to treat hairy cell leukemia.
Pentostatin (Nipent): Another chemotherapy option for this condition.
Mantle Cell Lymphoma Treatment Options
Temsirolimus (Torisel): A targeted therapy used in mantle cell lymphoma.
Bortezomib (Velcade): A proteasome inhibitor used in certain cases of mantle cell lymphoma.
Acute Lymphoblastic Leukemia (ALL) Treatment Options
Hyper-CVAD regimen: A chemotherapy regimen that includes cyclophosphamide, vincristine, doxorubicin, and dexamethasone.
Blinatumomab (Blincyto): A monoclonal antibody used in some cases of ALL.
Recent Updates on Idelalisib Research
Recent studies are focused on improving Idelalisib’s safety profile, particularly in relation to its effects on the immune system. Researchers are exploring ways to reduce the risk of infections and pneumonitis in patients taking Idelalisib. Ongoing clinical trials are also investigating the use of Idelalisib in combination with other targeted therapies to enhance its effectiveness in treating various B-cell malignancies. While these studies show promise, more research is needed to fully understand the long-term benefits and risks of these combinations.
